Literature DB >> 18096696

The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation.

Erika Peverelli1, Giovanna Mantovani, Davide Calebiro, Andrea Doni, Sara Bondioni, Andrea Lania, Paolo Beck-Peccoz, Anna Spada.   

Abstract

Somatostatin (SS) is a widely distributed polypeptide that exerts inhibitory effects on hormone secretion and cell proliferation by interacting with five different receptors (SST1-SST5). Beta-arrestins have been implicated in regulating SST internalization, but the structural domains mediating this effect are largely unknown. The aim of this study was to characterize the intracellular mechanisms responsible for internalization of human SST5 in the rat pituitary cell line GH3 and to identify the SST5 structural domains involved in this process. To this purpose we evaluated, by fluorescence microscopy and biochemical assay, the ability of wild-type, progressive C-terminal truncated and third cytoplasmatic loop mutants SST5-DsRed to associate with beta-arrestin-enhanced green fluorescent protein and to internalize under SS28 stimulation. The truncated mutants were comparable to the wild-type receptor with respect to recruitment of beta-arrestin-2 and internalization, whereas the third loop mutants R240W, S242A, and T247A showed the abolishment or reduction of arrestin association and a significant reduction of receptor internalization (14.4%, 29%, and 30.9% vs. 52.4% of wild type) and serine phosphorylation upon SS28 stimulation. Moreover, we evaluated the ability of simultaneous mutation of these three residues (R240, S242, and T247) and C-terminal truncated receptors to internalize. The progressive truncation of the C-terminal tail resulted in a progressive increased internalization (21.6%, 36.7%, and 41%, respectively) with respect to the full-length total third-loop mutant (15%). In conclusion, our results indicate the SST5 third intracellular loop as an important mediator of beta-arrestin/receptor interaction and receptor internalization, whereas they suggest that residues 328-347 within the C terminus may play an inhibitory role in receptor internalization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18096696      PMCID: PMC5419615          DOI: 10.1210/me.2007-0068

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  34 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

Review 2.  The therapeutic value of somatostatin and its analogues.

Authors:  S Farooqi; J S Bevan; M C Sheppard; J A Wass
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

Review 3.  Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization.

Authors:  Trudy A Kohout; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

Review 4.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

5.  Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells.

Authors:  D Roosterman; A Roth; H J Kreienkamp; D Richter; W Meyerhof
Journal:  J Neuroendocrinol       Date:  1997-10       Impact factor: 3.627

6.  Regulated endocytosis of G-protein-coupled receptors by a biochemically and functionally distinct subpopulation of clathrin-coated pits.

Authors:  T T Cao; R W Mays; M von Zastrow
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

7.  beta-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6.

Authors:  Emanuela Galliera; Venkatakrishna R Jala; John O Trent; Raffaella Bonecchi; Paola Signorelli; Robert J Lefkowitz; Alberto Mantovani; Massimo Locati; Bodduluri Haribabu
Journal:  J Biol Chem       Date:  2004-04-13       Impact factor: 5.157

8.  Distinct domains of the mu-opioid receptor control uncoupling and internalization.

Authors:  Jeremy Celver; Mei Xu; Wenzhen Jin; Janet Lowe; Charles Chavkin
Journal:  Mol Pharmacol       Date:  2004-03       Impact factor: 4.436

9.  The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization.

Authors:  N Hukovic; R Panetta; U Kumar; M Rocheville; Y C Patel
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

10.  Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.

Authors:  G Weckbecker; R Liu; L Tolcsvai; C Bruns
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

View more
  16 in total

1.  Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop.

Authors:  Erika Peverelli; Andrea G Lania; Giovanna Mantovani; Paolo Beck-Peccoz; Anna Spada
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

Review 2.  Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5.

Authors:  Stefan Schulz; Andreas Lehmann; Andrea Kliewer; Falko Nagel
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 3.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

4.  Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line.

Authors:  Valeria Cambiaghi; Eleonora Vitali; Diego Morone; Erika Peverelli; Anna Spada; Giovanna Mantovani; Andrea Gerardo Lania
Journal:  Endocrine       Date:  2016-07-12       Impact factor: 3.633

Review 5.  Pituitary somatostatin receptor signaling.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Trends Endocrinol Metab       Date:  2010-02-09       Impact factor: 12.015

6.  Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor.

Authors:  Aline Petrich; Anika Mann; Andrea Kliewer; Falko Nagel; Anne Strigli; Jan Carlo Märtens; Florian Pöll; Stefan Schulz
Journal:  Mol Endocrinol       Date:  2013-02-15

7.  The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.

Authors:  Guisheng Zhou; Marie-Claude Gingras; Shi-He Liu; Donghui Li; Zhijun Li; Robbi L Catania; Kelly M Stehling; Min Li; Giovanni Paganelli; Richard A Gibbs; Francesco J Demayo; William E Fisher; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 8.  Drug resistance in pituitary tumours: from cell membrane to intracellular signalling.

Authors:  Erika Peverelli; Donatella Treppiedi; Federica Mangili; Rosa Catalano; Anna Spada; Giovanna Mantovani
Journal:  Nat Rev Endocrinol       Date:  2021-06-30       Impact factor: 43.330

9.  Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas.

Authors:  Sanjeet G Patel; Guisheng Zhou; Shi-He Liu; Min Li; Jae-Wook Jeong; Francesco J DeMayo; Marie-Claude Gingras; Richard A Gibbs; William E Fisher; F Charles Brunicardi
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

Review 10.  Illuminating somatostatin analog action at neuroendocrine tumor receptors.

Authors:  Jean Claude Reubi; Agnes Schonbrunn
Journal:  Trends Pharmacol Sci       Date:  2013-10-31       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.